Literature DB >> 23356990

Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys.

Yoshiki Yamagami1, Tasuku Mashiba, Ken Iwata, Makoto Tanaka, Kazutoshi Nozaki, Tetsuji Yamamoto.   

Abstract

Suppression of bone remodeling by bisphosphonates leads to accumulation of microdamage in bone. If this microdamage develops due to suppressed repair of remodeling only, more potent bisphosphonates should cause more damage. In this study, we evaluated the effects of reduced bone turnover produced by a potent bisphosphonate, minodronic acid, on microdamage accumulation, the degree of mineralization and mechanical properties of bone in ovariectomized cynomolgus monkeys, and compared these effects with those of alendronate. Sixty female monkeys aged 9-17 years old were divided into five groups. The sham group and the ovariectomized group were treated daily for 17 months with lactose vehicle. The other three groups were treated daily with minodronic acid at a dose of 0.015 mg/kg or 0.15 mg/kg, or alendronate at 0.5mg/kg orally. After sacrifice, lumbar vertebrae and left femurs were subjected to histomorphometry, microdamage, mineralization analyses, and mechanical testing. Minodronic acid suppressed bone remodeling of cancellous and cortical bone in a dose-dependent manner and the higher dose of minodronic acid suppressed bone remodeling more strongly than alendronate. The lower dose of minodronic acid did not increase microdamage accumulation and compressive strength, but the higher dose of minodronic acid and alendronate resulted in similar increases in cancellous microdamage accumulation and ultimate load in lumbar vertebra. There were no significant differences among the groups in microdamage, degree of mineralization and mechanical properties in cortical bone of the femoral shaft; however, only alendronate showed a tendency to increase highly mineralized osteons and microdamage. These findings suggest that microdamage caused by minodronic acid is less than that expected based on the extent of remodeling suppression, in comparison with alendronate although this was not reflected in any significant change of mechanical properties.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23356990     DOI: 10.1016/j.bone.2013.01.016

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  16 in total

1.  Evaluation of crystallographic orientation of biological apatite in vertebral cortical bone in ovariectomized cynomolgus monkeys treated with minodronic acid and alendronate.

Authors:  Makoto Tanaka; Aira Matsugaki; Takuya Ishimoto; Takayoshi Nakano
Journal:  J Bone Miner Metab       Date:  2015-04-03       Impact factor: 2.626

2.  Histological and micro Computed Tomography analysis of a femoral stress fracture associated with prolonged bisphosphonate use.

Authors:  Matthijs Paul Somford; Leo J van Ruijven; Peter Kloen; Astrid D Bakker
Journal:  Clin Cases Miner Bone Metab       Date:  2017-05-30

3.  Effects of switching weekly alendronate or risedronate to monthly minodronate in patients with rheumatoid arthritis: a 12-month prospective study.

Authors:  K Ebina; T Noguchi; M Hirao; J Hashimoto; S Kaneshiro; M Yukioka; H Yoshikawa
Journal:  Osteoporos Int       Date:  2016-01       Impact factor: 4.507

4.  Atypical femoral fractures, bisphosphonates, and mechanical stress.

Authors:  Per Aspenberg; Jörg Schilcher
Journal:  Curr Osteoporos Rep       Date:  2014-06       Impact factor: 5.096

5.  Minodronic acid induces morphological changes in osteoclasts at bone resorption sites and reaches a level required for antagonism of purinergic P2X2/3 receptors.

Authors:  Makoto Tanaka; Akihiro Hosoya; Hiroshi Mori; Ryoji Kayasuga; Hiroaki Nakamura; Hidehiro Ozawa
Journal:  J Bone Miner Metab       Date:  2017-02-27       Impact factor: 2.626

6.  Reduced diaphyseal strength associated with high intracortical vascular porosity within long bones of children with osteogenesis imperfecta.

Authors:  Carolyne Albert; John Jameson; Peter Smith; Gerald Harris
Journal:  Bone       Date:  2014-06-11       Impact factor: 4.398

7.  Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.

Authors:  H P Bögl; P Aspenberg; J Schilcher
Journal:  Osteoporos Int       Date:  2017-05-04       Impact factor: 4.507

8.  The utility of bone scintigraphy in the assessment of mandibular metabolism during long-term bisphosphonate administration.

Authors:  Yumiko Ohbayashi; Fumi Nakai; Akinori Iwasaki; Takaaki Ogawa; Yuka Yamamoto; Yoshihiro Nishiyama; Minoru Miyake
Journal:  Odontology       Date:  2016-10-21       Impact factor: 2.634

Review 9.  The Role of Lower-Limb Geometry in the Pathophysiology of Atypical Femoral Fracture.

Authors:  Ifaz T Haider; Prism S Schneider; W Brent Edwards
Journal:  Curr Osteoporos Rep       Date:  2019-10       Impact factor: 5.096

10.  Localization of Minodronate in Mouse Femora Through Isotope Microscopy.

Authors:  Hiromi Hongo; Muneteru Sasaki; Sachio Kobayashi; Tomoka Hasegawa; Tomomaya Yamamoto; Kanako Tsuboi; Erika Tsuchiya; Tomoya Nagai; Naznin Khadiza; Miki Abe; Ai Kudo; Kimimitsu Oda; Paulo Henrique Luiz de Freitas; Minqi Li; Hisayoshi Yurimoto; Norio Amizuka
Journal:  J Histochem Cytochem       Date:  2016-10       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.